Perla Villamor
Clinical Instructor, Otolaryngology (Head and Neck Surgery)
Bio
Perla Villamor, MD, is a Clinical Instructor in the Clinician Educator line in the Department of Otolaryngology — Head & Neck Surgery and the Division of Pediatric Otolaryngology at Stanford University School of Medicine. She completed her medical and otolaryngology training in Colombia, followed by a pediatric otolaryngology fellowship in Mexico.
She has extensive experience in research, teaching, and clinical practice, having worked in leading institutions across Latin America and the Middle East.
Her passion for pediatric airway surgery has driven her to collaborate on global surgery initiatives and contribute to international scientific publications. She is deeply committed to working with children and their families to improve their quality of life and ensure they experience happy, healthy childhoods. She is currently pursuing a two-year International Fellowship in Complex Pediatric Otolaryngology at Stanford Children’s Hospital.
Clinical Focus
- Pediatric Otolaryngology
Academic Appointments
-
Clinical Instructor, Otolaryngology (Head and Neck Surgery)
Professional Education
-
Fellowship: National Autonomous University of Mexico (2019)
-
Residency: Fundacion Universitaria Ciencias de la Salud FUCS (2017) Colombia
-
Medical Education: Universidad de los Andes Faculty of Medicine (2010) Colombia
All Publications
-
Implementation and early outcomes of AI-powered ambient documentation in pediatric otolaryngology practice.
International journal of pediatric otorhinolaryngology
2026; 211: 113049
Abstract
Electronic health record (EHR) documentation contributes to clinician burnout, yet evidence on ambient artificial intelligence (AI) scribes in pediatric surgical subspecialties is limited. We evaluated adoption and documentation efficiency after implementing an ambient AI scribe in pediatric otolaryngology.In this retrospective quality-improvement study at a tertiary academic pediatric otolaryngology practice, an ambient AI scribe was introduced in March 2025. We analyzed initial rollout and a current-state window (January-July 2026), after early effects had stabilized, comprising 16 clinicians (12 physicians, 4 advanced practice providers [APPs]). Adoption and documentation time were derived from EHR efficiency dashboards for AI-assisted versus manual encounters. Utilization was compared by visit type and clinician role using chi-square tests and Cochran-Mantel-Haenszel analysis stratified by clinician.Practice-wide utilization rose from 17.6% of 1690 encounters at rollout to 39.2% the following quarter, and remained 39.9% of 11,565 encounters 10 months later. Adoption was bimodal (6 clinicians ≥50% of encounters; 5 < 10%). Utilization was higher among physicians than APPs (47.7% vs 10.9%; P < 0.001) and in new-patient than established visits (47.0% vs 34.7%; P < 0.001), persisting in clinician-stratified analysis (odds ratio 2.56; P < 0.001). All 16 clinicians remained in the same utilization tier throughout. Median note-editing time was lower with AI assistance (∼4.0 vs 11.8 min), while median note length was similar (∼4000 characters).Ambient AI scribe implementation was associated with rapid adoption sustained at both practice and individual clinician levels, and with reduced documentation time without increased note length, with particular value for clinicians lacking documentation support.
View details for DOI 10.1016/j.ijporl.2026.113049
View details for PubMedID 42893659
-
Recolonization dynamics of the middle ear microbiota following MESNA-assisted dissection in pediatric cholesteatomatous chronic otitis media.
Frontiers in cellular and infection microbiology
2026; 16: 1830192
Abstract
Cholesteatomatous chronic otitis media (CCOM) remains a clinical challenge due to its high recurrence rates despite surgical intervention. Sodium 2-mercaptoethanesulphonate (MESNA) is used to assist dissection, yet its impact on the middle ear microbiome and ecological recovery remains poorly understood. The aim of this study is to characterize the microbiota of paediatric CCOM and evaluate the ecological shifts induced by MESNA-assisted surgery.We analyzed 16S rRNA gene sequences (V3-V4) from middle ear tissue of paediatric patients with CCOM (CCOM Before MESNA, n = 13; CCOM After MESNA, n = 13) and healthy controls (n = 11). Bioinformatic processing was performed via QIIME2 and DADA2. We employed a Compositional Data Analysis (CoDA) framework, centering on Aitchison distances, ALDEx2 for differential abundance, and consensus co-occurrence networks (SparCC, SPIEC-EASI, and CLR-Pearson). Functional potential was inferred using PICRUSt2.CCOM was associated with a marked reduction in microbial network connectivity, decreasing from 185 edges in healthy controls to only two total edges in the CCOM Before MESNA stage. Cutibacterium emerged as a candidate keystone pathobiont, exhibiting profound ecological isolation and predicted metabolic shifts toward lipid catabolism and biofilm formation in dysbiotic states. MESNA application disrupted the disease-associated community equilibrium, initiating secondary succession. However, post-treatment recovery was marked by taxonomic homogenization and the expansion of Pseudomonas in several patients.Our findings identify network fragmentation and functional dysbiosis as the ecological signatures of pediatric CCOM. While MESNA disrupts the dysbiotic equilibrium, it does not fully restore a healthy stable climax community within the studied timeframe, as defined in ecological succession theory. These results support a paradigm shift from simple pathogen eradication toward ecological restoration as a strategy to prevent disease recurrence in CCOM patients.
View details for DOI 10.3389/fcimb.2026.1830192
View details for PubMedID 42256231
View details for PubMedCentralID PMC13236964